- Home
- WVE vs INTR Comparison
WVE vs INTR Comparison
Compare WVE & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- INTR
- Stock Information
- Founded
- WVE 2012
- INTR 1994
- Country
- WVE Singapore
- INTR Brazil
- Employees
- WVE N/A
- INTR N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- INTR
- Sector
- WVE Health Care
- INTR
- Exchange
- WVE Nasdaq
- INTR Nasdaq
- Market Cap
- WVE 2.1B
- INTR 2.0B
- IPO Year
- WVE 2015
- INTR N/A
- Fundamental
- Price
- WVE $13.70
- INTR $4.10
- Analyst Decision
- WVE Strong Buy
- INTR Strong Buy
- Analyst Count
- WVE 10
- INTR 4
- Target Price
- WVE $21.60
- INTR $7.13
- AVG Volume (30 Days)
- WVE 947.4K
- INTR 2.5M
- Earning Date
- WVE 11-12-2024
- INTR 02-05-2025
- Dividend Yield
- WVE N/A
- INTR 2.71%
- EPS Growth
- WVE N/A
- INTR 295.93
- EPS
- WVE N/A
- INTR 0.33
- Revenue
- WVE $53,610,000.00
- INTR $767,729,562.00
- Revenue This Year
- WVE N/A
- INTR N/A
- Revenue Next Year
- WVE $48.58
- INTR $23.65
- P/E Ratio
- WVE N/A
- INTR $13.28
- Revenue Growth
- WVE N/A
- INTR 38.44
- 52 Week Low
- WVE $3.50
- INTR $4.27
- 52 Week High
- WVE $16.74
- INTR $7.84
- Technical
- Relative Strength Index (RSI)
- WVE 48.19
- INTR 31.33
- Support Level
- WVE $13.11
- INTR $4.46
- Resistance Level
- WVE $15.54
- INTR $4.72
- Average True Range (ATR)
- WVE 0.89
- INTR 0.19
- MACD
- WVE -0.19
- INTR 0.02
- Stochastic Oscillator
- WVE 27.52
- INTR 2.75
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.